<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Faculty of Veterinary Medicine, Urmia University</PublisherName>
				<JournalTitle>Veterinary Research Forum</JournalTitle>
				<Issn>2008-8140</Issn>
				<Volume>10</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>12</Month>
					<Day>15</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Crocin exerts improving effects on indomethacin-induced small intestinal ulcer by antioxidant, anti-inflammatory and anti-apoptotic mechanisms</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>277</FirstPage>
			<LastPage>284</LastPage>
			<ELocationID EIdType="pii">35908</ELocationID>
			
<ELocationID EIdType="doi">10.30466/vrf.2018.93512.2256</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sadat</FirstName>
					<LastName>Ghafarzadeh</LastName>
<Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University</Affiliation>

</Author>
<Author>
					<FirstName>Rahim</FirstName>
					<LastName>Hobbenaghi</LastName>
<Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Esmaeal</FirstName>
					<LastName>Tamaddonfard</LastName>
<Affiliation>Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-8240-5885</Identifier>

</Author>
<Author>
					<FirstName>Amir Abbas</FirstName>
					<LastName>Farshid</LastName>
<Affiliation>Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University</Affiliation>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Imani</LastName>
<Affiliation>Department of Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-9990-4389</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2018</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract>Crocin is a plant-derived carotenoid and bears potent antioxidant property. Ranitidine (a histamine H&lt;sub&gt;2&lt;/sub&gt; receptor blocker) is used for peptic ulcer treatment. The present study was planned to investigate the effects of crocin and ranitidine on indomethacin-induced ulcer in small intestine of rats. Animals were randomized into two major groups including indo-methacin (10.00 mg kg&lt;sup&gt;-1&lt;/sup&gt;, ulcer group, 48 rats) and normal saline (1.00 mL kg&lt;sup&gt;-1&lt;/sup&gt;, intact group, 48 rats) groups. Each of these two major groups was subdivided into eight subgroups for intra-peritoneal (IP) injections of normal saline, crocin (2.50, 10.00 and 40.00 mg kg&lt;sup&gt;-1&lt;/sup&gt;), ranitidine (5.00 and 20.00 mg kg&lt;sup&gt;-1&lt;/sup&gt;), crocin (2.50 and 10.00 mg kg&lt;sup&gt;-1&lt;/sup&gt;) plus ranitidine (5.00 mg kg&lt;sup&gt;-1&lt;/sup&gt;). Indomethacin induced intestinal ulcer was characterized by bleeding, inflammation, epithelial hyperplasia and crypt loss. This non-steroidal anti-inflammatory drug (NSAID), indomethacin decreased goblet cell number and superoxide dismutase (SOD) activity and increased small intestine weight, organo-somatic index (OSI), malodealdehyde (MDA), tumor necrosis factor-α (TNF-α) and caspase-3 contents of intestine. Crocin resolved all the above-mentioned parameter changes induced by indomethacin. These treatments produced no significant effects on the above-mentioned parameters of intact group. The results of the present study showed tissue protective and anti-ulcer effects of crocin on small intestine by antioxidant, anti-inflammatory and anti-apoptotic mechanisms. Ranitidine alone showed no effect; however, in combination with crocin it exerted recovery effects. It is recommended that crocin, be considered as a therapeutic agent for NSAIDs-induced intestinal damage management.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Crocin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Indomethacin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ranitidine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">small intestinal ulcer</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://vrf.iranjournals.ir/article_35908_fdba654832c8c610f18259f903659075.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
